MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Is sprint running exercise feasible, safe and enjoyable to subjects with mild-to-moderate Parkinson’s disease?

    E. Monteiro, L. Peyré-Tartaruga, E. da Silva, A. Zanardi, P. Jimenez-Reyes, J. Morin, A. Pagnussat (Porto Alegre, Brazil)

    Objective: To test the feasibility, safety, and acceptance of sprint running exercise in subjects with mild-to-moderate Parkinson’s disease (PD). Background: Positive effects of sprint running…
  • 2019 International Congress

    Inflammatory cytokines in Saudi Parkinson cohort

    N. Alsomali, E. Al-Ofi, M. Obaid, A. Alrafiah (Riyadh, Saudi Arabia)

    Objective: To identify inflammatory diagnostic and prognostic biomarkers for PD in serum. Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's…
  • 2019 International Congress

    A review of interactive voice response systems in Parkinson’s Disease

    J. Domingues, T. Guerreiro, D. Branco, A. Rodrigues, R. Bouça-Machado, J. Ferreira (Aveiro, Portugal)

    Objective: The objective of this literature revision is to review and analyze the current research on the uses of Interactive Voice Response Systems (IVRS) in…
  • 2019 International Congress

    Opsoclonus and ataxia in the setting of synchronous primary malignancies

    H. Leal Bailey, S. Wijemanne Sarathkumara, R. Knightstep (San Antonio, TX, USA)

    Objective: To present a rare case of opsoclonus with positive anti-Ri (ANNA-2) autoantibodies, secondary to synchronous multiple primary tumors. Background: Opsoclonus refers to involuntary, conjugate, saccadic…
  • 2019 International Congress

    Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting

    A. Podlewska, D. van Wamelen, A. Sauerbier, V. Leta, D. Trivedi, M. Parry, K. Ray Chaudhuri (Lodnon, United Kingdom)

    Objective: To explore the usefulness of wearable sensor data to inform treatment decisions in PD. Background: Wearable sensors are becoming increasingly incorporated into clinical care…
  • 2019 International Congress

    Metabolomic Analysis of Fecal Matter from Parkinsonian Mice

    V. Vedam-Mai, E. Gill, J. Koelmel, R. Yost, T. Garrett, M. Okun (Gainesville, FL, USA)

    Objective: Assess the metabolic changes in fecal matter in mice treated with an immunomodulatory therapy. Background: The cause of neuronal death in Parkinson’s disease (PD)…
  • 2019 International Congress

    The effects of timed exposure to bright light in improving the gait patterns of patients with Parkinson’s disease – A pilot study

    L. Alibiglou, T. Ruopp (Tehran, Islamic Republic of Iran)

    Objective: To investigate the impact of timed exposure to bright light (TEBL) on improving gait function in medicated PD patients with dyskinesias (PD+DYS) and without…
  • 2019 International Congress

    The Efficacy and Safety of Subcutaneous Apomorphine in Patients with Parkinson’s Disease: A Meta-Analysis Randomized Controlled Trials

    M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

    Objective: The objective of this study to evaluate the efficacy and safety of subcutaneous apomorphine for patients with Parkinson’s disease (PD). Background: Subcutaneous apomorphine has…
  • 2019 International Congress

    Abnormal Intracortical Facilitation in patients of Parkinson’s disease with REM Sleep Behavior Disorder

    A. Bhattacharya, N. Kamble, R. Yadav, PK Pal

    Objective: To evaluate the motor cortical excitability changes in PD patients with and without RBD. Background: There has been an increase in the understanding of…
  • 2019 International Congress

    Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study

    S. Castillo-Torres, C. Soto-Rincón, D. Cantú-García, A. Mendoza-Garcia, D. Díaz-Pérez, D. Martínez-Roque, B. Chávez-Luévanos, I. Estrada-Bellmann, F. Góngora-Rivera (Monterrey, Mexico)

    Objective: To determine the clinical correlates of carotid intima media thickess in patients with idiopathic Parkinson’s disease (PD). Background: Subclinical cardiovascular disease has been suggested…
  • « Previous Page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley